{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:38:22Z","timestamp":1794627502605,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["NS108025"],"award-info":[{"award-number":["NS108025"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["AG069229"],"award-info":[{"award-number":["AG069229"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health"},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1IK6 BX004982"],"award-info":[{"award-number":["1IK6 BX004982"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pathways to control the spreading of \u03b1-synuclein (\u03b1-syn) and associated neuropathology in Parkinson\u2019s disease (PD), multiple system atrophy (MSA) and dementia with Lewy bodies (DLB) are unclear. Here, we show that preformed \u03b1-syn fibrils (PFF) increase the association between TLR2 and MyD88, resulting in microglial activation. The TLR2-interaction domain of MyD88 (wtTIDM) peptide-mediated selective inhibition of TLR2 reduces PFF-induced microglial inflammation in vitro. In PFF-seeded A53T mice, the nasal administration of the wtTIDM peptide, NEMO-binding domain (wtNBD) peptide, or genetic deletion of TLR2 reduces glial inflammation, decreases \u03b1-syn spreading, and protects dopaminergic neurons by inhibiting NF-\u03baB. In summary, \u03b1-syn spreading depends on the TLR2\/MyD88\/NF-\u03baB pathway and it can be reduced by nasal delivery of wtTIDM and wtNBD peptides.<\/jats:p>","DOI":"10.1038\/s41467-021-25767-1","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T06:03:22Z","timestamp":1631253802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":194,"title":["Selective targeting of the TLR2\/MyD88\/NF-\u03baB pathway reduces \u03b1-synuclein spreading in vitro and in vivo"],"prefix":"10.1038","volume":"12","author":[{"given":"Debashis","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malabendu","family":"Jana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumita","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanta","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avik","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6048-9598","authenticated-orcid":false,"given":"Kalipada","family":"Pahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"key":"25767_CR1","unstructured":"Feigin, V. L. et al. Global, regional and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 459\u2013480 (2019)."},{"key":"25767_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1750-3639.2002.tb00468.x","volume":"12","author":"R Betarbet","year":"2002","unstructured":"Betarbet, R., Sherer, T. B., Di Monte, D. A. & Greenamyre, J. T. Mechanistic approaches to Parkinson\u2019s disease pathogenesis. Brain Pathol. 12, 499\u2013510 (2002).","journal-title":"Brain Pathol."},{"key":"25767_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0304-3940(99)00311-0","volume":"266","author":"TA Bayer","year":"1999","unstructured":"Bayer, T. A. et al. Alpha-synuclein accumulates in Lewy bodies in Parkinson\u2019s disease and dementia with Lewy bodies but not in Alzheimer\u2019s disease beta-amyloid plaque cores. Neurosci. Lett. 266, 213\u2013216 (1999).","journal-title":"Neurosci. Lett."},{"key":"25767_CR4","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/cne.23901","volume":"524","author":"K Taguchi","year":"2016","unstructured":"Taguchi, K., Watanabe, Y., Tsujimura, A. & Tanaka, M. Brain region-dependent differential expression of alpha-synuclein. J. Comp. Neurol. 524, 1236\u20131258 (2016).","journal-title":"J. Comp. Neurol."},{"key":"25767_CR5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00702-004-0263-3","volume":"112","author":"A Hofer","year":"2005","unstructured":"Hofer, A. et al. The role of alpha-synuclein gene multiplications in early-onset Parkinson\u2019s disease and dementia with Lewy bodies. J. Neural Transm. 112, 1249\u20131254 (2005).","journal-title":"J. Neural Transm."},{"key":"25767_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrneurol.2013.275","volume":"10","author":"HJ Lee","year":"2014","unstructured":"Lee, H. J., Bae, E. J. & Lee, S. J. Extracellular alpha\u2013synuclein-a novel and crucial factor in Lewy body diseases. Nat. Rev. Neurol. 10, 92\u201398 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"25767_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim, C. et al. Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat. Commun. 4, 1562 (2013).","journal-title":"Nat. Commun."},{"key":"25767_CR8","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats, P. et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl Acad. Sci. USA 106, 13010\u201313015 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25767_CR9","doi-asserted-by":"publisher","first-page":"11835","DOI":"10.1523\/JNEUROSCI.0983-17.2017","volume":"37","author":"J Rostami","year":"2017","unstructured":"Rostami, J. et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J. Neurosci. 37, 11835\u201311853 (2017).","journal-title":"J. Neurosci."},{"key":"25767_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4161\/oxim.3.4.12809","volume":"3","author":"HJ Lee","year":"2010","unstructured":"Lee, H. J., Kim, C. & Lee, S. J. Alpha-synuclein stimulation of astrocytes: Potential role for neuroinflammation and neuroprotection. Oxid. Med. Cell Longev. 3, 283\u2013287 (2010).","journal-title":"Oxid. Med. Cell Longev."},{"key":"25767_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.4049\/jimmunol.0903480","volume":"185","author":"EJ Lee","year":"2010","unstructured":"Lee, E. J. et al. Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1. J. Immunol. 185, 615\u2013623 (2010).","journal-title":"J. Immunol."},{"key":"25767_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nature02761","volume":"430","author":"B Beutler","year":"2004","unstructured":"Beutler, B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 257\u2013263 (2004).","journal-title":"Nature"},{"key":"25767_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nri3446","volume":"13","author":"LA O\u2019Neill","year":"2013","unstructured":"O\u2019Neill, L. A., Golenbock, D. & Bowie, A. G. The history of Toll-like receptors - redefining innate immunity. Nat. Rev. Immunol. 13, 453\u2013460 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"25767_CR14","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1172\/JCI96209","volume":"128","author":"SB Rangasamy","year":"2018","unstructured":"Rangasamy, S. B. et al. Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer\u2019s pathology. J. Clin. Invest. 128, 4297\u20134312 (2018).","journal-title":"J. Clin. Invest."},{"key":"25767_CR15","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.celrep.2015.09.044","volume":"13","author":"C Kim","year":"2015","unstructured":"Kim, C. et al. Antagonizing neuronal toll-like receptor 2 prevents synucleinopathy by activating autophagy. Cell Rep. 13, 771\u2013782 (2015).","journal-title":"Cell Rep."},{"key":"25767_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun, S. P. et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat. Med. 24, 931\u2013938 (2018).","journal-title":"Nat. Med."},{"key":"25767_CR17","unstructured":"Mao, X. et al. Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science 353, aah3374 (2016)."},{"key":"25767_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-017-0182-z","volume":"12","author":"ZA Sorrentino","year":"2017","unstructured":"Sorrentino, Z. A. et al. Intrastriatal injection of alpha-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity. Mol. Neurodegener. 12, 40 (2017).","journal-title":"Mol. Neurodegener."},{"key":"25767_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949\u2013953 (2012).","journal-title":"Science"},{"key":"25767_CR20","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee, M. K. et al. Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53\u2013> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl Acad. Sci. USA 99, 8968\u20138973 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25767_CR21","doi-asserted-by":"publisher","first-page":"18754","DOI":"10.1073\/pnas.0704908104","volume":"104","author":"A Ghosh","year":"2007","unstructured":"Ghosh, A. et al. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease. Proc. Natl Acad. Sci. USA 104, 18754\u201318759 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25767_CR22","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1126\/science.289.5484.1550","volume":"289","author":"MJ May","year":"2000","unstructured":"May, M. J. et al. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289, 1550\u20131554 (2000).","journal-title":"Science"},{"key":"25767_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/13550280802578075","volume":"15","author":"N Khanlou","year":"2009","unstructured":"Khanlou, N. et al. Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J. Neurovirol 15, 131\u2013138 (2009).","journal-title":"J. Neurovirol"},{"key":"25767_CR24","doi-asserted-by":"crossref","unstructured":"Kuhbandner, K. et al. alpha-Synuclein: a modulator during inflammatory CNS demyelination. J. Mol. Neurosci. 70, 1038\u20131049 (2020).","DOI":"10.1007\/s12031-020-01498-8"},{"key":"25767_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/JAD-150040","volume":"47","author":"SB Rangasamy","year":"2015","unstructured":"Rangasamy, S. B. et al. Intranasal delivery of NEMO-binding domain peptide prevents memory loss in a mouse model of Alzheimer\u2019s disease. J. Alzheimers Dis. 47, 385\u2013402 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"25767_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5755","volume":"5","author":"EJ Bae","year":"2014","unstructured":"Bae, E. J. et al. Glucocerebrosidase depletion enhances cell-to-cell transmission of alpha-synuclein. Nat. Commun. 5, 4755 (2014).","journal-title":"Nat. Commun."},{"key":"25767_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuroscience.2012.02.004","volume":"208","author":"P Barkholt","year":"2012","unstructured":"Barkholt, P., Sanchez-Guajardo, V., Kirik, D. & Romero-Ramos, M. Long-term polarization of microglia upon alpha-synuclein overexpression in nonhuman primates. Neuroscience 208, 85\u201396 (2012).","journal-title":"Neuroscience"},{"key":"25767_CR28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1471-4159.2012.07805.x","volume":"122","author":"G Stoica","year":"2012","unstructured":"Stoica, G. et al. Potential role of alpha-synuclein in neurodegeneration: studies in a rat animal model. J. Neurochem. 122, 812\u2013822 (2012).","journal-title":"J. Neurochem"},{"key":"25767_CR29","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4161\/auto.19371","volume":"8","author":"J Klucken","year":"2012","unstructured":"Klucken, J. et al. Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway. Autophagy 8, 754\u2013766 (2012).","journal-title":"Autophagy"},{"key":"25767_CR30","doi-asserted-by":"crossref","unstructured":"Stefanis, L. et al. How is alpha-synuclein cleared from the cell? J. Neurochem. 150, 577\u2013590 (2019).","DOI":"10.1111\/jnc.14704"},{"key":"25767_CR31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/bpa.12373","volume":"26","author":"E Emmanouilidou","year":"2016","unstructured":"Emmanouilidou, E. & Vekrellis, K. Exocytosis and spreading of normal and aberrant alpha-synuclein. Brain Pathol. 26, 398\u2013403 (2016).","journal-title":"Brain Pathol."},{"key":"25767_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s10571-018-0622-5","volume":"38","author":"G Gustafsson","year":"2018","unstructured":"Gustafsson, G. et al. Secretion and uptake of alpha-synuclein via extracellular vesicles in cultured cells. Cell Mol. Neurobiol. 38, 1539\u20131550 (2018).","journal-title":"Cell Mol. Neurobiol."},{"key":"25767_CR33","doi-asserted-by":"publisher","first-page":"175909141881258","DOI":"10.1177\/1759091418812587","volume":"10","author":"J Cheng","year":"2018","unstructured":"Cheng, J., Lu, Q., Song, L. & Ho, M. S. alpha-Synuclein trafficking in Parkinson\u2019s disease: insights from fly and mouse models. ASN Neuro. 10, 1759091418812587 (2018).","journal-title":"ASN Neuro"},{"key":"25767_CR34","doi-asserted-by":"crossref","unstructured":"Gordon, R. et al. Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci. Transl. Med. 10, eaah4066 (2018).","DOI":"10.1126\/scitranslmed.aah4066"},{"key":"25767_CR35","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee, H. J. et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J. Biol. Chem. 285, 9262\u20139272 (2010).","journal-title":"J. Biol. Chem."},{"key":"25767_CR36","doi-asserted-by":"crossref","unstructured":"Izco, M., Blesa, J., Verona, G., Cooper, J. M. & Alvarez-Erviti, L. Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson\u2019s disease. Neurosci. Res. 170, 330\u2013340 (2020).","DOI":"10.1016\/j.neures.2020.11.004"},{"key":"25767_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00401-016-1648-8","volume":"133","author":"N Dzamko","year":"2017","unstructured":"Dzamko, N. et al. Toll-like receptor 2 is increased in neurons in Parkinson\u2019s disease brain and may contribute to alpha-synuclein pathology. Acta Neuropathol. 133, 303\u2013319 (2017).","journal-title":"Acta Neuropathol."},{"key":"25767_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5607\/en.2016.25.3.113","volume":"25","author":"C Kim","year":"2016","unstructured":"Kim, C., Lee, H. J., Masliah, E. & Lee, S. J. Non-cell-autonomous neurotoxicity of alpha-synuclein through microglial toll-like receptor 2. Exp. Neurobiol. 25, 113\u2013119 (2016).","journal-title":"Exp. Neurobiol."},{"key":"25767_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-018-0276-2","volume":"13","author":"C Kim","year":"2018","unstructured":"Kim, C. et al. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating alpha-synuclein transmission and neuroinflammation. Mol. Neurodegener. 13, 43 (2018).","journal-title":"Mol. Neurodegener."},{"key":"25767_CR40","doi-asserted-by":"publisher","first-page":"108895","DOI":"10.1016\/j.celrep.2021.108895","volume":"34","author":"K Russ","year":"2021","unstructured":"Russ, K. et al. TNF-alpha and alpha-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration. Cell Rep. 34, 108895 (2021).","journal-title":"Cell Rep."},{"key":"25767_CR41","doi-asserted-by":"publisher","first-page":"9564814","DOI":"10.1155\/2016\/9564814","volume":"2016","author":"HM Johnson","year":"2016","unstructured":"Johnson, H. M., Ahmed, C. M. & Noncanonical, I. F. N. Signaling: mechanistic linkage of genetic and epigenetic events. Mediators Inflamm. 2016, 9564814 (2016).","journal-title":"Mediators Inflamm."},{"key":"25767_CR42","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.freeradbiomed.2004.11.021","volume":"38","author":"M Jana","year":"2005","unstructured":"Jana, M., Anderson, J. A., Saha, R. N., Liu, X. & Pahan, K. Regulation of inducible nitric oxide synthase in proinflammatory cytokine-stimulated human primary astrocytes. Free Radic. Biol. Med. 38, 655\u2013664 (2005).","journal-title":"Free Radic. Biol. Med."},{"key":"25767_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15813-8","volume":"7","author":"M Karampetsou","year":"2017","unstructured":"Karampetsou, M. et al. Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice. Sci. Rep. 7, 16533 (2017).","journal-title":"Sci. Rep."},{"key":"25767_CR44","doi-asserted-by":"crossref","unstructured":"Rangasamy, S. B. et al. Selective disruption of TLR2\/MyD88 interaction inhibits inflammation and attenuates Alzheimer\u2019s pathology. J. Clin. Invest. 128, 4297\u20134312 (2018).","DOI":"10.1172\/JCI96209"},{"key":"25767_CR45","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11481-012-9377-9","volume":"7","author":"S Mondal","year":"2012","unstructured":"Mondal, S. et al. Testing NF-kappaB-based therapy in hemiparkinsonian monkeys. J. Neuroimmune Pharm. 7, 544\u2013556 (2012).","journal-title":"J. Neuroimmune Pharm."},{"key":"25767_CR46","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s11064-007-9340-y","volume":"32","author":"M Jana","year":"2007","unstructured":"Jana, M., Jana, A., Pal, U. & Pahan, K. A simplified method for isolating highly purified neurons, oligodendrocytes, astrocytes, and microglia from the same human fetal brain tissue. Neurochem. Res. 32, 2015\u20132022 (2007).","journal-title":"Neurochem. Res."},{"key":"25767_CR47","doi-asserted-by":"publisher","first-page":"7254","DOI":"10.4049\/jimmunol.181.10.7254","volume":"181","author":"M Jana","year":"2008","unstructured":"Jana, M., Palencia, C. A. & Pahan, K. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer\u2019s disease. J. Immunol. 181, 7254\u20137262 (2008).","journal-title":"J. Immunol."},{"key":"25767_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11481-017-9771-4","volume":"13","author":"G Chandra","year":"2018","unstructured":"Chandra, G. et al. Increase in mitochondrial biogenesis in neuronal cells by RNS60, a physically-modified saline, via phosphatidylinositol 3-kinase-mediated upregulation of PGC1alpha. J. Neuroimmune Pharm. 13, 143\u2013162 (2018).","journal-title":"J. Neuroimmune Pharm."},{"key":"25767_CR49","doi-asserted-by":"publisher","first-page":"7872","DOI":"10.1007\/s12035-019-01649-y","volume":"56","author":"CG Gottschalk","year":"2019","unstructured":"Gottschalk, C. G., Roy, A., Jana, M., Kundu, M. & Pahan, K. Activation of peroxisome proliferator-activated receptor-alpha increases the expression of nuclear receptor related 1 protein (Nurr1) in dopaminergic neurons. Mol. Neurobiol. 56, 7872\u20137887 (2019).","journal-title":"Mol. Neurobiol."},{"key":"25767_CR50","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s12035-016-0328-y","volume":"55","author":"D Dutta","year":"2018","unstructured":"Dutta, D. et al. Low levels of prohibitin in substantia nigra makes dopaminergic neurons vulnerable in Parkinson\u2019s disease. Mol. Neurobiol. 55, 804\u2013821 (2018).","journal-title":"Mol. Neurobiol."},{"key":"25767_CR51","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/nchembio.2204","volume":"12","author":"A Roy","year":"2016","unstructured":"Roy, A. et al. Identification and characterization of PPARalpha ligands in the hippocampus. Nat. Chem. Biol. 12, 1075\u20131083 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"25767_CR52","doi-asserted-by":"publisher","first-page":"10309","DOI":"10.1074\/jbc.M114.610659","volume":"290","author":"A Ghosh","year":"2015","unstructured":"Ghosh, A. et al. Activation of peroxisome proliferator-activated receptor alpha induces lysosomal biogenesis in brain cells: implications for lysosomal storage disorders. J. Biol. Chem. 290, 10309\u201310324 (2015).","journal-title":"J. Biol. Chem."},{"key":"25767_CR53","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1046\/j.1471-4159.2003.01864.x","volume":"86","author":"M Jana","year":"2003","unstructured":"Jana, M., Dasgupta, S., Saha, R. N., Liu, X. & Pahan, K. Induction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12 p40 monomer and homodimer in microglia and macrophages. J. Neurochem. 86, 519\u2013528 (2003).","journal-title":"J. Neurochem."},{"key":"25767_CR54","doi-asserted-by":"publisher","first-page":"29529","DOI":"10.1074\/jbc.M111.338012","volume":"287","author":"S Khasnavis","year":"2012","unstructured":"Khasnavis, S. et al. Suppression of nuclear factor-kappaB activation and inflammation in microglia by physically modified saline. J. Biol. Chem. 287, 29529\u201329542 (2012).","journal-title":"J. Biol. Chem."},{"key":"25767_CR55","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11481-020-09979-8","volume":"16","author":"RK Paidi","year":"2021","unstructured":"Paidi, R. K. et al. ACE-2-interacting domain of SARS-CoV-2 (AIDS) peptide suppresses inflammation to reduce fever and protect lungs and heart in mice: implications for COVID-19 Therapy. J. Neuroimmune Pharm. 16, 59\u201370 (2021).","journal-title":"J. Neuroimmune Pharm."},{"key":"25767_CR56","doi-asserted-by":"publisher","first-page":"E7408","DOI":"10.1073\/pnas.1802021115","volume":"115","author":"D Patel","year":"2018","unstructured":"Patel, D. et al. Aspirin binds to PPARalpha to stimulate hippocampal plasticity and protect memory. Proc. Natl Acad. Sci. USA 115, E7408\u2013E7417 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25767_CR57","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11481-018-9808-3","volume":"14","author":"SB Rangasamy","year":"2019","unstructured":"Rangasamy, S. B., Dasarathi, S., Pahan, P., Jana, M. & Pahan, K. Low-dose aspirin upregulates tyrosine hydroxylase and increases dopamine production in dopaminergic neurons: implications for Parkinson\u2019s disease. J. Neuroimmune Pharm. 14, 173\u2013187 (2019).","journal-title":"J. Neuroimmune Pharm."},{"key":"25767_CR58","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.4049\/jimmunol.1700149","volume":"198","author":"G Chandra","year":"2017","unstructured":"Chandra, G., Roy, A., Rangasamy, S. B. & Pahan, K. Induction of adaptive immunity leads to nigrostriatal disease progression in MPTP mouse model of Parkinson\u2019s disease. J. Immunol. 198, 4312\u20134326 (2017).","journal-title":"J. Immunol."},{"key":"25767_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","volume":"73","author":"K Matsuura","year":"1997","unstructured":"Matsuura, K., Kabuto, H., Makino, H. & Ogawa, N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J. Neurosci. Methods 73, 45\u201348 (1997).","journal-title":"J. Neurosci. Methods"},{"key":"25767_CR60","doi-asserted-by":"publisher","first-page":"13543","DOI":"10.1523\/JNEUROSCI.4144-09.2009","volume":"29","author":"A Ghosh","year":"2009","unstructured":"Ghosh, A. et al. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson\u2019s disease. J. Neurosci. 29, 13543\u201313556 (2009).","journal-title":"J. Neurosci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25767-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25767-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25767-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:33:13Z","timestamp":1669973593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25767-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25767"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25767-1","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/H16FRC","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,10]]},"assertion":[{"value":"11 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5382"}}